Henry Schein upgraded by UBS with a new price target

Media roundtable sessions: "Conversations with Henry Schein: Exploring the Present and Future of Oral Health" will take place to discuss digitalization in dentistry; Henry Schein will also feature "FDI's Integrated Electronic Health Records Project." The Company will present an expansive portfolio of products and solutions, designed to help oral health professionals enhance practice efficiency and the patient experience, and will offer endodontic hands-on courses with Key Opinion Leaders at the booth. Henry Schein, Inc. (NASDAQ:HSIC) will showcase a selection of its comprehensive business and practice solutions, and provide perspectives on the future of dentistry, during the 2025 Inter

With This Donation, The Company Promotes Wellness, Prevention, and Health Education for Athletes With Intellectual Disabilities Around the World Henry Schein, Inc. – the world's largest provider of health care solutions to office-based dental and medical practitioners – is supporting the Special Olympics Healthy Athletes® screenings at the Special Olympics World Winter Games Turin 2025, which take place from March 8 to 15, 2025, in Turin, Italy. The organization is donating a range of oral health and medical products essential to overall health and wellness. During the Healthy Athletes Ribbon Cutting Ceremony, on March 8, 2025, Henry Schein was recognized for these contributions. Healthy A

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience PureTech Health plc (NASDAQ:PRTC, LSE: PRTC)) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, ("Seaport") a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that Robert "Bob" J. Hombach has been appointed to its Board of Directors and will serve as the Chair of the Audit Committee. Mr. Hombach is a seasoned financial and operational executive with three decades of high-level leadership in the healthca

Wells Fargo initiated coverage of Henry Schein with a rating of Equal Weight and set a new price target of $80.00

BofA Securities upgraded Henry Schein from Underperform to Buy and set a new price target of $84.00 from $69.00 previously

Mizuho initiated coverage of Henry Schein with a rating of Neutral and set a new price target of $75.00

4 - HENRY SCHEIN INC (0001000228) (Issuer)

4 - HENRY SCHEIN INC (0001000228) (Issuer)

4 - HENRY SCHEIN INC (0001000228) (Issuer)

8-K - HENRY SCHEIN INC (0001000228) (Filer)

10-K - HENRY SCHEIN INC (0001000228) (Filer)

8-K - HENRY SCHEIN INC (0001000228) (Filer)

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience PureTech Health plc (NASDAQ:PRTC, LSE: PRTC)) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, ("Seaport") a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that Robert "Bob" J. Hombach has been appointed to its Board of Directors and will serve as the Chair of the Audit Committee. Mr. Hombach is a seasoned financial and operational executive with three decades of high-level leadership in the healthca

Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that Robert "Bob" J. Hombach has been appointed to its Board of Directors and will serve as the Chair of the Audit Committee. Mr. Hombach is a seasoned financial and operational executive with three decades of high-level leadership in the healthcare sector. His experience includes serving on the Audit, Finance and Compensation Committees for several public and private Boards of

The American Dental Association Foundation's Initiative, with Exclusive National Sponsors Henry Schein and Colgate-Palmolive, Continues to Expand Its Reach, With Nearly 325,500 Children Expected to Receive Care Throughout 2025 The American Dental Association Foundation (ADA Foundation) is celebrating the 23rd year of its Give Kids A Smile® (GKAS) program, which officially launched on Friday, February 7, at the 2025 national kick-off event at Meharry Medical College School of Dentistry. Since its national launch in 2003, GKAS volunteers have provided free oral health education and services to more than 9.5 million underserved children in the U.S. This press release features multimedia. Vi

Fourth-quarter 2024 GAAP diluted EPS of $0.74 and non-GAAP diluted EPS of $1.19 Fourth-quarter 2024 operating cash flow of $204 million; full-year 2024 operating cash flow of $848 million, up $348 million compared with 2023 2025 non-GAAP diluted EPS expected to be in the range of $4.80 to $4.94 with mid-single digit 2025 Adjusted EBITDA growth Announces new reportable segments to provide more meaningful information for investors Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the fourth quarter and full year ended December 28, 2024. The financial result

KKR to become 12% common shareholder in Henry Schein Henry Schein and KKR to collaborate on range of value creation opportunities Two KKR representatives with deep sector experience to join the Henry Schein Board as independent directors Separately, Robert J. Hombach, who brings extensive financial and strategic experience in health care, has joined the Henry Schein Board as an independent director Announces preliminary unaudited fourth-quarter 2024 GAAP diluted EPS of $0.74 and non-GAAP diluted EPS of $1.19, and preliminary 2025 financial guidance for full-year non-GAAP EPS of low to mid single digit growth In addition, Henry Schein has increased its share repurchase progra

Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its fourth quarter and full-year 2024 financial results before the stock market opens on Tuesday, February 25, 2025, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay

SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)

SC 13G - HENRY SCHEIN INC (0001000228) (Subject)

SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)